Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage

Abstract Background Cervical cancer (CC) is the third most common gynecological malignancy around the world. Cisplatin is an effective drug, but cisplatin resistance is a vital factor limiting the clinical usage of cisplatin. Enhancer of mRNA decapping protein 4 (EDC4) is a known regulator of mRNA d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Xiaoling Wu, Youwen Zhong, Qing Chen, Xin Zhang, Hua Zhang
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-10-01
Colecção:Hereditas
Assuntos:
Cervical Cancer
Cisplatin resistance
Enhancer of mRNA decapping protein 4 (EDC4)
Replication protein a (RPA)
DNA damage
Acesso em linha:http://link.springer.com/article/10.1186/s41065-020-00154-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados